KEGG: mpt:Mpe_A1656
STRING: 420662.Mpe_A1656
Mpe_A1656 is a UPF0060 family membrane protein from Methylibium petroleiphilum consisting of 112 amino acids. The full amino acid sequence is: MLDFLRVTGLFFVTAVAEIVGCYLPWLVLTQGRSAWLLVPAAASLAVFAWLLTLHPSAAGRTYAAYGGVYVVVALLWLWRVDGVVPTRWDLVGGAICLAGMAIIALQPRAAS . Structural analysis indicates it is a transmembrane protein with hydrophobic regions that likely span the bacterial membrane. When expressed recombinantly, it is typically fused to an N-terminal His-tag to facilitate purification while maintaining its native conformation .
To maintain optimal activity, Mpe_A1656 should be stored at -20°C/-80°C in aliquots to prevent repeated freeze-thaw cycles. The recommended storage buffer is a Tris/PBS-based buffer containing 6% Trehalose at pH 8.0, or alternatively, a Tris-based buffer with 50% glycerol . For working solutions, store aliquots at 4°C for no more than one week. When reconstituting lyophilized protein, briefly centrifuge the vial before opening and reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL, adding glycerol to a final concentration of 5-50% for long-term storage .
E. coli is the preferred expression system for Mpe_A1656, as documented in multiple successful expressions . When designing an expression strategy, consider using a vector with a temperature-responsive promoter such as pL or cspA promoters, which allow tight regulation of protein expression . The cspA promoter is particularly effective for membrane proteins as it is highly responsive to low temperatures, directing the synthesis of over 13% of bacterial proteins during cold shock response . E. coli strains containing the host integration factor (HIF) are recommended when using vectors with the pL promoter to enhance expression efficiency .
A methodical purification approach for His-tagged Mpe_A1656 involves the following steps:
Cell lysis: Use gentle lysis conditions to preserve membrane protein integrity
Initial capture: Apply lysate to Ni-NTA or similar affinity resin
Washing: Remove non-specific binding proteins with incremental imidazole concentrations
Elution: Use higher imidazole concentration (250-300 mM) buffer
Quality assessment: Verify purity via SDS-PAGE (should exceed 90%)
To distinguish full-length proteins from truncated products, consider using expression vectors with fusion tags on both ends and increase the imidazole concentration during elution . For membrane proteins like Mpe_A1656, include appropriate detergents in your buffers to maintain solubility throughout the purification process .
For systematic documentation of purification results, implement a structured data table as follows:
| Purification Step | Volume (mL) | Total Protein (mg) | Mpe_A1656 (mg) | Purity (%) | Specific Activity | Recovery (%) |
|---|---|---|---|---|---|---|
| Crude Extract | 100 | |||||
| Ni-NTA Capture | ||||||
| Size Exclusion | ||||||
| Final Product |
This format follows established guidelines for scientific data tables, with the independent variable (purification step) in the left column and dependent variables (measurements) in subsequent columns . Include a derived quantity column (e.g., recovery percentage) to evaluate purification efficiency across different preparations.
To determine the membrane topology of Mpe_A1656, employ a multi-technique approach:
Computational analysis: Use hydropathy plots and transmembrane prediction algorithms to identify potential membrane-spanning regions in the sequence MLDFLRVTGLFFVTAVAEIVGCYLPWLVLTQGRSAWLLVPAAASLAVFAWLLTLHPSAAGRTYAAYGGVYVVVALLWLWRVDGVVPTRWDLVGGAICLAGMAIIALQPRAAS
Protease accessibility assays: Treat membrane vesicles containing Mpe_A1656 with proteases to identify protected regions
Cysteine scanning mutagenesis: Systematically replace amino acids with cysteine and probe accessibility with thiol-reactive reagents
Fluorescence resonance energy transfer (FRET): Engineer fluorescent protein tags at putative intracellular and extracellular domains
Record results in a comprehensive table that correlates predicted transmembrane segments with experimental evidence, noting discrepancies that might indicate unique structural features of this UPF0060 family protein.
To identify interaction partners of Mpe_A1656, implement complementary experimental strategies:
Pull-down assays: Use His-tagged Mpe_A1656 as bait to capture interacting proteins from Methylibium petroleiphilum lysates
Bacterial two-hybrid screening: Construct fusion proteins to detect protein-protein interactions in vivo
Cross-linking studies: Apply membrane-permeable cross-linkers to stabilize transient interactions before isolation
Co-immunoprecipitation: Develop antibodies against Mpe_A1656 for immunoprecipitation of protein complexes
Proximity-dependent biotin labeling: Fuse Mpe_A1656 to a biotin ligase to identify proteins in close proximity in vivo
Document all potential interacting partners in a relational database that includes detection method, statistical significance, and biological context to prioritize candidates for validation studies.
To determine the biological role of Mpe_A1656, implement a systematic research strategy:
Gene deletion studies: Create knockout strains of Methylibium petroleiphilum lacking the Mpe_A1656 gene and analyze phenotypic changes
Complementation analysis: Reintroduce wild-type or mutated versions of Mpe_A1656 to knockout strains to verify functional restoration
Transcriptomic profiling: Compare gene expression patterns between wild-type and knockout strains under various conditions
Metabolomic analysis: Identify metabolic pathways affected by Mpe_A1656 deletion
Stress response characterization: Test sensitivity of knockout strains to various stressors (osmotic pressure, pH changes, membrane-disrupting agents)
While limited information exists about specific pathways involving Mpe_A1656 , systematically document all phenotypic changes in knockout versus wild-type strains to generate hypotheses about its functional role in Methylibium petroleiphilum physiology.
For comprehensive structure-function analysis, employ these targeted mutagenesis approaches:
Alanine scanning: Systematically replace conserved residues with alanine to identify functionally critical amino acids
Charge reversal mutations: Modify charged residues to opposite charges to probe electrostatic interactions
Domain swapping: Exchange putative functional domains with homologous proteins to test domain-specific functions
Truncation analysis: Create series of N- and C-terminal truncations to identify minimal functional units
Site-directed mutagenesis of predicted active sites: Target specific residues based on structural homology to better-characterized UPF0060 family proteins
For each mutant, assess expression level, membrane localization, and functional parameters to create a comprehensive mutation-function relationship map of the protein.
When encountering difficulties expressing Mpe_A1656, implement this systematic troubleshooting workflow:
Codon optimization: Analyze the Mpe_A1656 sequence for rare codons in E. coli and optimize accordingly, as hydrophobic membrane proteins with rare codons often cause expression difficulties
Promoter selection: Test different promoter systems, particularly temperature-responsive promoters like cspA that enhance expression at low temperatures (15-16°C)
Expression strain evaluation: Compare expression levels in different E. coli strains, particularly those designed for membrane protein expression
Fusion tag optimization: Test various fusion partners (beyond His-tag) that can enhance solubility and expression
Induction conditions: Systematically vary temperature, inducer concentration, and induction duration
Document all optimization attempts in a structured format to identify patterns that lead to successful expression of this membrane protein.
To enhance the solubility and stability of Mpe_A1656 during and after purification:
Detergent screening: Test multiple detergent types and concentrations (non-ionic, zwitterionic, etc.) for optimal extraction and stability
Buffer optimization: Systematically vary buffer components (salt concentration, pH, additives) to identify stabilizing conditions
Addition of lipids or cholesterol: Include specific lipids that may enhance membrane protein stability
Analyze aggregation propensity: Use analytical techniques (size exclusion chromatography, dynamic light scattering) to monitor aggregation state
Stabilizing additives: Test glycerol, trehalose, arginine, or specific ion combinations known to stabilize membrane proteins
Record stability data over time under different conditions to develop an evidence-based protocol for maintaining Mpe_A1656 in its native conformation during experimental procedures.